Page last updated: 2024-11-05

thiotepa and Peritoneal Carcinomatosis

thiotepa has been researched along with Peritoneal Carcinomatosis in 13 studies

Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).

Research Excerpts

ExcerptRelevanceReference
" With this rationale a clinical phase I and pharmacokinetic study of intraperitoneally administered N, N', N'' triethylenethiophosphoramide (thiotepa), an alkylating agent with activity against ovarian carcinoma, was initiated with the objectives of determining the systemic and local toxicities, maximum-tolerated dose, and pharmacokinetic advantage associated with using the drug in this manner."1.28Phase I clinical and pharmacokinetic study of thiotepa administered intraperitoneally in patients with advanced malignancies. ( Egorin, MJ; Runowicz, CD; Salva, K; Tortorello, L; Wadler, S; Wiernik, PH; Zuhowski, EG, 1989)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-199012 (92.31)18.7374
1990's1 (7.69)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
NECHAEVA, ID1
Vinokurov, VL1
Mitrokhina, MV1
Spratt, JS1
Adcock, RA1
Muskovin, M1
Sherrill, W1
McKeown, J1
Irzhanov, SI1
Serov, SF1
Brenner, J1
Sordillo, PP1
Magill, GB1
Legha, SS1
Muggia, FM1
Chauffert, B1
Dimanche-Boitrel, MT1
Genne, P1
Petit, JM1
Onier, N1
Jeannin, JF1
Wadler, S1
Egorin, MJ1
Zuhowski, EG1
Tortorello, L1
Salva, K1
Runowicz, CD1
Wiernik, PH1
Schwandt, P1
Ehrhart, H1
Magell, J1
Limber, GK1
King, RE1
Silverberg, SG1
Gerner, RE1
Moore, GE1
Maliugina, LL1
Pol'kina, RI1
Remizov, AL1
Petrov, AS1
Kraĭz, BO1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
BEV-IP: Perioperative Chemotherapy With Bevacizumab in Patients Undergoing Cytoreduction and Intraperitoneal Chemoperfusion for Colorectal Carcinomatosis[NCT02399410]Phase 260 participants (Actual)Interventional2015-12-31Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

2 reviews available for thiotepa and Peritoneal Carcinomatosis

ArticleYear
Malignant mesothelioma in children: report of seven cases and review of the literature.
    Medical and pediatric oncology, 1981, Volume: 9, Issue:4

    Topics: Adolescent; Brain Neoplasms; Child; Child, Preschool; Female; Humans; Lung Neoplasms; Male; Mesothel

1981
Therapeutic approaches in malignant mesothelioma.
    Cancer treatment reviews, 1977, Volume: 4, Issue:1

    Topics: Alkylating Agents; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy,

1977

Other Studies

11 other studies available for thiotepa and Peritoneal Carcinomatosis

ArticleYear
[DATA ON THE USE OF THIO-TEPA IN COMBINED TREATMENT OF PATIENTS WITH MALIGNANT OVARIAN TUMORS].
    Voprosy onkologii, 1963, Volume: 9

    Topics: Adnexa Uteri; Choriocarcinoma; Cystadenoma; Cystadenoma, Mucinous; Dermoid Cyst; Female; Humans; Hys

1963
[Intratumor chemotherapy of patients with cancer of the ovaries].
    Voprosy onkologii, 1983, Volume: 29, Issue:8

    Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Cyst

1983
Clinical delivery system for intraperitoneal hyperthermic chemotherapy.
    Cancer research, 1980, Volume: 40, Issue:2

    Topics: Adult; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Cystadenoma; Drug Therapy, C

1980
[Mitotic activity changes in serous ovarian cystadenocarcinomas under treated with chemotherapy].
    Voprosy onkologii, 1980, Volume: 26, Issue:10

    Topics: Adult; Aged; Cystadenoma; Dose-Response Relationship, Drug; Female; Humans; Lymphatic Metastasis; Mi

1980
[Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats].
    Gastroenterologie clinique et biologique, 1992, Volume: 16, Issue:3

    Topics: Animals; Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclophosphamide; Disease Models, Anim

1992
Phase I clinical and pharmacokinetic study of thiotepa administered intraperitoneally in patients with advanced malignancies.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Blood Proteins; Drug Evaluation; Female; Humans; Infusions, Parenter

1989
[Local treatment of carcinomatous effusions with triethylenethiophosphoramide (thio-tepa)].
    Munchener medizinische Wochenschrift (1950), 1966, Dec-16, Volume: 108, Issue:50

    Topics: Aged; Exudates and Transudates; Female; Humans; Male; Middle Aged; Palliative Care; Peritoneal Neopl

1966
Pseudomyxoma peritonei.
    Lancet (London, England), 1969, Oct-18, Volume: 2, Issue:7625

    Topics: Cystadenoma; Female; Humans; Ovarian Neoplasms; Peritoneal Neoplasms; Thiotepa

1969
Pseudomyxoma peritonaei: a report of ten cases.
    Annals of surgery, 1973, Volume: 178, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Appendectomy; Appendiceal Neoplasms; Castration; Cystadenoma; Female; F

1973
Chemotherapy of malignant mesothelioma.
    Oncology, 1974, Volume: 30, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Female; Fluorouracil; Glucosamine; Humans; Male; Mesothelioma; M

1974
[The anti-tumor effect of several mono- and di-chlor-sym.triazine derivatives].
    Voprosy onkologii, 1970, Volume: 16, Issue:6

    Topics: Animals; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Female; Leukopenia; Lung Neoplasms; Lympho

1970